Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
The Perth Blood Institute Limited
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • Who we are
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
      • Thrombosis Australia Advisory Panel
    • Work with us
  • Our clinical trials
    • Clinical trials
    • Collaborations
    • Participate in a clinical trial
    • Useful links
  • Our research
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Blood disorders
      • Anaemia
      • Antiphospholipid syndrome (APS)
      • Haemophilia
      • Polycythemia vera
      • Thrombocythaemia
      • Thrombophilia
      • TTP
      • von Willebrand Disease
    • Blood cancers
      • Myelofibrosis (MF)
      • Chronic lymphocytic leukaemia
      • Lymphoma
    • For patients and families
  • Personal stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Partner with us
    • Leave a gift in your will
    • Other ways to help
  • News and events
    • Latest news & info
    • Previous news
    • 10 Year Anniversary
    • Significant days
      • 2023
      • 2022
    • Media
    • Upcoming events
    • Publications
  • COVID-19
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)
  • Thrombocythaemia

Thrombocythaemia

        Thrombocythaemia is a disorder where the body produces too many platelets. When the cause is an underlying condition from infection, inflammation or iron deficiency it is called ‘reactive’ or ‘secondary’ thrombocytosis. Primary thrombocytosis is when there is no obvious or known cause for the high platelet count; also referred to as ‘primary’ or ‘essential’ thrombocythaemia (ET), which is a blood or bone marrow disease.

        Your bone marrow contains stem cells which develop into platelets, and the large number of platelets are produced when faulty or defective bone marrow cells don’t work properly. Thrombocythaemia is mostly caused by mutations or changes in the genes that control how your bone marrow forms platelets, and therefore is a condition which can be inherited.

        Myelofibrosis and polycythaemia vera (PV) are associated with primary thrombocytosis. Both ET and PV are myeloproliferative neoplasm disorders, which refers to when bone marrow produces blood cells in a rapid and uncontrolled way. Visit our website to read more about Polycythemia vera and Myelofibrosis.

        Statistics

        Essential thrombocythaemia is more common in women than men and usually between the ages of 50-70 years. In 2019, a review article reported the following data and clinical features associated with ET:

        • Incidence of ET was estimated at 1.2 to 3.0 per 100,000 population per year.
        • A retrospective study with 1076 patients with ET conducted by the Mayo Clinic, found the average age at diagnosis was 58 years; 67% were women; leukocytosis was documented in 26% of patients, and a history of thrombosis at or before diagnosis was present in 21%.
        • Other features included headaches, visual disturbances, light-headedness, dysesthesia (symptoms related to the skin – itching, burning, tingling, stinging, tickling, crawling or cold sensation, pain); and less frequently, erythromelalgia (a burning dysesthesia associated with red discoloration of the hands or feet).
        • After an average follow-up period of 10 years, death had occurred in 43%, myelofibrosis in 13%, and new thrombosis in 21%.

        Symptoms

        Most people do not have any symptoms and therefore the disorder is usually only discovered during blood tests for another condition. A high platelet count is linked to blood clots and bleeding.

        Blood clots generally occur in the brain, hands and feet, causing long-term chronic headaches and dizziness. The risk of a blood clot increases if you have clots in the past, smoke, have diabetes or high blood pressure. In severe cases there is the possibility of a transient ischaemic attack or stroke.

        Other possible symptoms associated with a blood clot include:

        • Hands and feet – numbness, burning feeling and throbbing pain.
        • Confusion or changes in speech
        • Migraines
        • Seizures
        • Upper body discomfort (jaw, neck, arms, back, abdomen)
        • Weakness
        • Chest pain
        • Enlarged spleen
        • Pregnancy complications

        Bleeding occurs as a result of the elevated platelet count causing ‘bad’ blood clots to develop and depleting the body platelet levels. Without this reservoir of platelets, the body cannot form a ‘good’ clot to seal off any cuts and so the risk of bleeding increases. Symptoms include:

        • Nosebleeds
        • Bruising
        • Bleeding in your mouth and gums
        • Blood in your stool
        • Cuts and breaks in blood vessels which don’t seal.

        Elevated platelet count and pregnancy

        Blood clots caused from an excessively high platelet count can hinder blood flow to the baby. Complications associated with clots and bleeding include:

        • High blood pressure
        • Slow growth of the unborn baby
        • Premature delivery
        • Separation of the placenta from the womb
        • Loss of pregnancy

        References

        • Platelet Disorders - Thrombocythemia and Thrombocytosis | NHLBI, NIH
        • Thrombocytosis - Symptoms and causes - Mayo Clinic
        • Neurocutaneous disease: Neurocutaneous dysesthesias - PubMed (nih.gov)
        • Thrombocytosis: Causes, Symptoms, Treatment, and More (verywellhealth.com)
        • Ayalew, T., & Animesh, P. (2019). Essential thrombocythemia. The New England Journal of Medicine, 381(22), 2135-2144. https://doi.org/10.1056/NEJMcp1816082.
        • Tefferi, A., & Barbui, T. (2019). Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol,94(1):133-143. doi: 10.1002/ajh.25303.

        Published: 10th August, 2023

        Updated: 17th August, 2023

        Author: Gina Rodgers

        Share this page
        • Email
        • Facebook
        • Twitter

        Latest

        • World Heart Day 2023

          World Heart Day 2023

          September 29th is World Heart Day. It is important to KNOW your heart and TAKE CARE of your heart.

        • In memory of Graham

          In memory of Graham

          Graham Wild, a passionate 15-year-old boy with a deep love for nature and animals, he had dreams of running an animal sanctuary. After returning from a trip to see his dad, Graham started to have trouble breathing and his health rapidly deteriorated. Despite urgent medical attention, his heart stopped, and he couldn't be revived. Graham's mother Kathryn would like to share his story.

        • Blood Cancer Awareness Month 2023

          Blood Cancer Awareness Month 2023

          Blood cancers are a complex group of cancers which can affect anyone, at any age, and at any time throughout their lives. September is Blood Cancer Awareness Month and here we present some information about this type of cancer.

        • Lymphoma

          Lymphoma

          Lymphoma or lymphatic cancer is a disease which attacks white blood cells and affects not only the organs associated with the lymphatic system but can impact other organs in the body. Here we provide some background information associated with this type of blood cancer.

        Related

        • Polycythemia vera

          Polycythemia vera

          Polycythemia vera is a rare type of blood cancer known as a ‘myeloproliferative disorder’ which refers to when bone marrow produces blood cells in a rapid and uncontrolled way.

        • Antiphospholipid syndrome (APS)

          Antiphospholipid syndrome (APS)

          Antiphospholipid syndrome (APS) is a rare acquired pre-thrombotic autoimmune disease. Here we provide some information regarding the condition.

        • Anaemia Fact Sheet

          Anaemia Fact Sheet

          Anaemia is a serious global health concern, predominantly affecting children and pregnant women. The World Health Organization (WHO) estimates that 42% of children under age 5 and 40% of pregnant women around the world suffer from anaemia. Learn more here.

        • von Willebrand Disease (VWD)

          VWD is an inherited bleeding disorder and is one of the most common bleeding disorders worldwide. Here we provide some background information about the disease.

        • Haemophilia

          Haemophilia

          Haemophilia is a X-linked blood disorder which is estimated to affect 400,000 persons globally. Here we provide some information about Haemophilia A and B.

        • Thrombophilia

          Thrombophilia

          Thrombophilia is an abnormal coagulation process which can be inherited or acquired. It results in a hypercoagulable state and increases the risk of thrombotic events where blood clots can form in either the arteries or veins.

        • TTP (Thrombotic Thrombocytopenic Purpura)

          TTP (Thrombotic Thrombocytopenic Purpura)

          TTP is a rare life-threatening blood disorder with an annual incidence of 3 to 11 cases per million people. Here is a review of the condition.

        Most read

        • What is thrombosis?

          What is thrombosis?

          Click here to learn more about thrombosis.

        • What are DVT & PE?

          What are DVT & PE?

          Click here to learn more about DVT and PE.

        • Work and Thrombosis

          Work and Thrombosis

          Click here to learn more about how work can increase your risk of thrombosis, and how to prevent it.

        • Travel and Thrombosis

          Travel and Thrombosis

          Click here to learn about how travel can increase your risk of developing dangerous blood clots.

        • Antiphospholipid Antibody Syndrome

          Antiphospholipid Antibody Syndrome

          Click here for information about antiphospholipid antibody syndrome and how it can lead to thrombosis.

        • Contraception and Thrombosis

          Contraception and Thrombosis

          Click here to learn more about how certain contraceptives can increase your risk of dangerous blood clots.

        • Inherited Thrombophilias

          Inherited Thrombophilias

          Click here for information about genetic conditions that can increase the chances of thrombosis.

        • Investigators

          Investigators

        • Participate in a clinical trial

          Participate in a clinical trial

          PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers.

        • Pregnancy and Thrombosis

          Pregnancy and Thrombosis

          Click here to learn about how pregnancy can increase your risk of thrombosis.

        Tag cloud

        Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA
        Donate today

        Donate today

        Please help to make blood disorders a thing of the past. Every amount is vital to our research, no matter how large or small. Read more

        Donate Fundraise

        Published: 18th February, 2020

        Updated: 8th May, 2023

        Author:

        SUPERNOVA clinical trial

        SUPERNOVA clinical trial

        Perth Blood Institute (PBI) start new Australian-wide clinical trial – SUPERNOVA Read more

        Published: 3rd July, 2023

        Updated: 2nd August, 2023

        Author: Gina Rodgers

        Comments: 1

        PBI celebrates 10 Year Anniversary!

        PBI celebrates 10 Year Anniversary!

        "It is with your support that we have continued to grow over the past 10 years – to continue to advance medical discoveries and improve care for patients. " Professor Ross Baker Read more

        Published: 4th July, 2023

        Updated: 21st September, 2023

        Author: Bec Morgan

        Graham Wild

        Graham Wild

        Graham Wild, a passionate 15-year-old boy with a deep love for nature and animals, had dreams of running an animal sanctuary. After returning from a trip to see his dad, Graham started to have trouble breathing and his health rapidly deteriorated. Despite urgent medical attention, his heart stopped, and he couldn't be revived. Graham's mother Kathryn would like to share his story. Read more

        Published: 13th July, 2023

        Updated: 14th September, 2023

        Author: Jacqui Le

        Sign up for our newsletter

        Please enter your first name
        Please enter your last name
        Please enter your email address Please enter a valid email address (e.g. [email protected])

        Helpful links

        • Sitemap
        • Accessibility
        • Terms & conditions
        • Privacy policy
        • Contact us

        Contact

        18 Prowse Street
        West Perth
        WA 6005
        P : +61 8 9200 5300
        F : +61 8 9200 5324
        E : [email protected]

        • Facebook
        • Instagram
        • Linkedin
        • Email

        PBI is registered as an Income Tax Exempt Charity
        CFN: CC21886
        ACN: 164 941 815
        ABN: 24 164 941 815

        © Perth Blood Institute 2020